Health Trials

Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

ConditionsAcute Renal Failure (ARF)Acute Tubular Necrosis
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age10-80
SponsorEbima Clifford Okundaye

About this trial

Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure

Eligibility criteria

Qualifiers

Hospitalized patients

presence of Acute renal failure

Nephrologist diagnosis of Acute tubular necrosis or fractional excretion of sodium of >2%

willingness to participate

Disqualifiers

None

Trial design

Treatments tested in this trial

  • QRX-3

Treatment groups

500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ebima Clifford Okundaye

Lead sponsor

Neukidney Inc.

Sponsor institution

Source ClinicalTrials.gov